| GENSIGHT BIOLOGICS |
| Frankreich |
| Gesundheit |
| FR0013183985 / A2ANGZ |
| G49N (Frankfurt) |
| FRA:G49N, ETR:G49N, G49N:GR |
| - |
| https://www.gensight-biol.. |
|
GenSight Biologics S.A. is a clinical-stage biotechnology company specializing in gene therapies for neurodegenerative retinal diseases and central nervous system disorders. Its mission centers on preserving or restoring vision in patients with sever..
>Volltext.. |
| 20.33 Mio. EUR |
| 30.78 Mio. EUR |
| - |
| -11.69 Mio. EUR |
| -12.25 Mio. EUR |
| -0.08 EUR |
| 13.09 Mio. EUR |
| 2.46 Mio. EUR |
| -9.33 Mio. EUR |
| 0.19 |
| -99.93% |
| 14.03% |
| - |
| - |
| - |
| - |
| GENSIGHT |
| 05.04.26 |
|